These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20610737)

  • 1. Interplay of palmitoylation and phosphorylation in the trafficking and localization of phosphodiesterase 10A: implications for the treatment of schizophrenia.
    Charych EI; Jiang LX; Lo F; Sullivan K; Brandon NJ
    J Neurosci; 2010 Jul; 30(27):9027-37. PubMed ID: 20610737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation.
    Kotera J; Sasaki T; Kobayashi T; Fujishige K; Yamashita Y; Omori K
    J Biol Chem; 2004 Feb; 279(6):4366-75. PubMed ID: 14604994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2.
    Sano H; Nagai Y; Miyakawa T; Shigemoto R; Yokoi M
    J Neurochem; 2008 Apr; 105(2):546-56. PubMed ID: 18088367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
    Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
    Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.
    Russwurm C; Koesling D; Russwurm M
    J Biol Chem; 2015 May; 290(19):11936-47. PubMed ID: 25762721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase.
    Xie Z; Adamowicz WO; Eldred WD; Jakowski AB; Kleiman RJ; Morton DG; Stephenson DT; Strick CA; Williams RD; Menniti FS
    Neuroscience; 2006 May; 139(2):597-607. PubMed ID: 16483723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A.
    Strick CA; James LC; Fox CB; Seeger TF; Menniti FS; Schmidt CJ
    Neuropharmacology; 2010 Feb; 58(2):444-51. PubMed ID: 19765598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.
    Padovan-Neto FE; Sammut S; Chakroborty S; Dec AM; Threlfell S; Campbell PW; Mudrakola V; Harms JF; Schmidt CJ; West AR
    J Neurosci; 2015 Apr; 35(14):5781-91. PubMed ID: 25855188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
    Leuti A; Laurenti D; Giampà C; Montagna E; Dato C; Anzilotti S; Melone MA; Bernardi G; Fusco FR
    Neurobiol Dis; 2013 Apr; 52():104-16. PubMed ID: 23220622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
    D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
    J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
    Giampà C; Laurenti D; Anzilotti S; Bernardi G; Menniti FS; Fusco FR
    PLoS One; 2010 Oct; 5(10):e13417. PubMed ID: 20976216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.
    Harada A; Suzuki K; Miura S; Hasui T; Kamiguchi N; Ishii T; Taniguchi T; Kuroita T; Takano A; Stepanov V; Halldin C; Kimura H
    Nucl Med Biol; 2015 Feb; 42(2):146-54. PubMed ID: 25451212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase 10A in the rat pineal gland: localization, daily and seasonal regulation of expression and influence on signal transduction.
    Spiwoks-Becker I; Wolloscheck T; Rickes O; Kelleher DK; Rohleder N; Weyer V; Spessert R
    Neuroendocrinology; 2011; 94(2):113-23. PubMed ID: 21474921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.
    Suzuki K; Harada A; Suzuki H; Miyamoto M; Kimura H
    Neuropsychopharmacology; 2016 Aug; 41(9):2252-62. PubMed ID: 26849714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
    Nishi A; Kuroiwa M; Miller DB; O'Callaghan JP; Bateup HS; Shuto T; Sotogaku N; Fukuda T; Heintz N; Greengard P; Snyder GL
    J Neurosci; 2008 Oct; 28(42):10460-71. PubMed ID: 18923023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of PDE10A in the rat brain.
    Seeger TF; Bartlett B; Coskran TM; Culp JS; James LC; Krull DL; Lanfear J; Ryan AM; Schmidt CJ; Strick CA; Varghese AH; Williams RD; Wylie PG; Menniti FS
    Brain Res; 2003 Sep; 985(2):113-26. PubMed ID: 12967715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.
    Giorgi M; Melchiorri G; Nuccetelli V; D'Angelo V; Martorana A; Sorge R; Castelli V; Bernardi G; Sancesario G
    Neurobiol Dis; 2011 Jul; 43(1):293-303. PubMed ID: 21515371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PDE10A inhibitor, papaverine, differentially activates ERK in male and female rat striatal slices.
    Hsu YT; Liao G; Bi X; Oka T; Tamura S; Baudry M
    Neuropharmacology; 2011 Dec; 61(8):1275-81. PubMed ID: 21816164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.
    Ooms M; Attili B; Celen S; Koole M; Verbruggen A; Van Laere K; Bormans G
    J Neurochem; 2016 Dec; 139(5):897-906. PubMed ID: 27664396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.
    Threlfell S; Sammut S; Menniti FS; Schmidt CJ; West AR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):785-95. PubMed ID: 19056933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.